Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1993 Nov;56(11):1200–1206. doi: 10.1136/jnnp.56.11.1200

Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register.

A M Chancellor 1, J M Slattery 1, H Fraser 1, C P Warlow 1
PMCID: PMC489821  PMID: 8229031

Abstract

In order to identify risk factors for the subsequent development of motor neuron disease (MND) we have carried out a case-control study of incident patients in Scotland, identified using the Scottish Motor Neuron Disease Register. A standard questionnaire was given to 103 patients and the same number of community controls matched on a one to one basis using the general practitioner's (GP) age and sex register. Recall bias was minimised by using GP records to verify the subject's report. There was an overall lifetime excess of fractures in patients, odds ratio (OR) = 1.3 (95% confidence interval (CI), 0.7-2.5) and this was highest in the 5 years before symptom onset (OR = 15, 95% CI, 3.3-654). There was no association with non-fracture trauma but the OR for a manual occupation in patients was 2.6 (95% CI, 1.1-6.3). Both occupational exposure to lead (OR = 5.7, 95% CI, 1.6-30) and solvents/chemicals (OR = 3.3, 95% CI 1.3-10) were significantly more common in patients. No consistent association was found between MND and factors reflecting socioeconomic deprivation in childhood; childhood infections or social class. Our results identify a number of different factors which may contribute to the aetiology of MND.

Full text

PDF
1205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASK-UPMARK E. Amyotrophic lateral sclerosis observed in 5 persons after gastric resection. Gastroenterology. 1950 Jun;15(2):257–259. [PubMed] [Google Scholar]
  2. Abarbanel J. M., Herishanu Y., Frisher S. Motor neuron disease in textile factory workers. Isr J Med Sci. 1985 Nov;21(11):924–925. [PubMed] [Google Scholar]
  3. Adams C. R., Ziegler D. K., Lin J. T. Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA. 1983 Aug 5;250(5):642–643. [PubMed] [Google Scholar]
  4. Armon C., Kurland L. T., Daube J. R., O'Brien P. C. Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology. 1991 Jul;41(7):1077–1084. doi: 10.1212/wnl.41.7.1077. [DOI] [PubMed] [Google Scholar]
  5. Barber T. E. Inorganic mercury intoxication reminiscent of amyotrophic lateral sclerosis. J Occup Med. 1978 Oct;20(10):667–669. [PubMed] [Google Scholar]
  6. Boothby J. A., DeJesus P. V., Rowland L. P. Reversible forms of motor neuron disease. Lead "neuritis". Arch Neurol. 1974 Jul;31(1):18–23. doi: 10.1001/archneur.1974.00490370044005. [DOI] [PubMed] [Google Scholar]
  7. Buckley J., Warlow C., Smith P., Hilton-Jones D., Irvine S., Tew J. R. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry. 1983 Mar;46(3):197–205. doi: 10.1136/jnnp.46.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Calne D. B., Eisen A., McGeer E., Spencer P. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet. 1986 Nov 8;2(8515):1067–1070. doi: 10.1016/s0140-6736(86)90469-1. [DOI] [PubMed] [Google Scholar]
  9. Campbell A. M., Williams E. R., Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):877–885. doi: 10.1136/jnnp.33.6.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Campbell A. M., Williams E. R., Pearce J. Late motor neuron degeneration following poliomyelitis. Neurology. 1969 Nov;19(11):1101–1106. doi: 10.1212/wnl.19.11.1101. [DOI] [PubMed] [Google Scholar]
  11. Cavalleri A., Minoia C., Ceroni M., Poloni M. Lead in cerebrospinal fluid and its relationship to plasma lead in humans. J Appl Toxicol. 1984 Apr;4(2):63–65. doi: 10.1002/jat.2550040202. [DOI] [PubMed] [Google Scholar]
  12. Chancellor A. M., Warlow C. P. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1106–1115. doi: 10.1136/jnnp.55.12.1106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chancellor A. M., Warlow C. P., Carstairs V., Elton R. A., Swingler R. J. Affluence, age, and motor neuron disease. J Epidemiol Community Health. 1992 Apr;46(2):172–173. doi: 10.1136/jech.46.2.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Conradi S., Ronnevi L. O., Nise G., Vesterberg O. Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid. J Neurol Sci. 1980 Dec;48(3):413–418. doi: 10.1016/0022-510x(80)90112-4. [DOI] [PubMed] [Google Scholar]
  15. Conradi S., Ronnevi L. O., Norris F. H. Motor neuron disease and toxic metals. Adv Neurol. 1982;36:201–231. [PubMed] [Google Scholar]
  16. Conradi S., Ronnevi L. O., Vesterberg O. Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry. J Neurol Neurosurg Psychiatry. 1978 May;41(5):389–393. doi: 10.1136/jnnp.41.5.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dalakas M. C. Amyotrophic lateral sclerosis and post-polio: differences and similarities. Birth Defects Orig Artic Ser. 1987;23(4):63–81. [PubMed] [Google Scholar]
  18. Dalakas M. C., Elder G., Hallett M., Ravits J., Baker M., Papadopoulos N., Albrecht P., Sever J. A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med. 1986 Apr 10;314(15):959–963. doi: 10.1056/NEJM198604103141505. [DOI] [PubMed] [Google Scholar]
  19. Deapen D. M., Henderson B. E. A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol. 1986 May;123(5):790–799. doi: 10.1093/oxfordjournals.aje.a114308. [DOI] [PubMed] [Google Scholar]
  20. Fletcher N. A., Harding A. E., Marsden C. D. The relationship between trauma and idiopathic torsion dystonia. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):713–717. doi: 10.1136/jnnp.54.8.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gallagher J. P., Sanders M. Apparent motor neuron disease following the use of pneumatic tools. Ann Neurol. 1983 Dec;14(6):694–695. doi: 10.1002/ana.410140620. [DOI] [PubMed] [Google Scholar]
  22. Gallagher J. P., Sanders M. Trauma and amyotrophic lateral sclerosis: a report of 78 patients. Acta Neurol Scand. 1987 Feb;75(2):145–150. doi: 10.1111/j.1600-0404.1987.tb07909.x. [DOI] [PubMed] [Google Scholar]
  23. Gallagher J. P., Talbert O. R. Motor neuron syndrome after electric shock. Acta Neurol Scand. 1991 Feb;83(2):79–82. doi: 10.1111/j.1600-0404.1991.tb04653.x. [DOI] [PubMed] [Google Scholar]
  24. Gawel M., Zaiwalla Z., Rose F. C. Antecedent events in motor neuron disease. J Neurol Neurosurg Psychiatry. 1983 Nov;46(11):1041–1043. doi: 10.1136/jnnp.46.11.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Granieri E., Carreras M., Tola R., Paolino E., Tralli G., Eleopra R., Serra G. Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology. 1988 Oct;38(10):1604–1608. doi: 10.1212/wnl.38.10.1604. [DOI] [PubMed] [Google Scholar]
  26. Graves A. B., White E., Koepsell T. D., Reifler B. V., van Belle G., Larson E. B., Raskind M. The association between head trauma and Alzheimer's disease. Am J Epidemiol. 1990 Mar;131(3):491–501. doi: 10.1093/oxfordjournals.aje.a115523. [DOI] [PubMed] [Google Scholar]
  27. Graziano J. H., Blum C. Lead exposure from lead crystal. Lancet. 1991 Jan 19;337(8734):141–142. doi: 10.1016/0140-6736(91)90803-w. [DOI] [PubMed] [Google Scholar]
  28. Gunnarsson L. G., Bodin L., Söderfeldt B., Axelson O. A case-control study of motor neurone disease: its relation to heritability, and occupational exposures, particularly to solvents. Br J Ind Med. 1992 Nov;49(11):791–798. doi: 10.1136/oem.49.11.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gunnarsson L. G., Lindberg G. Amyotrophic lateral sclerosis in Sweden 1970-83 and solvent exposure. Lancet. 1989 Apr 29;1(8644):958–958. doi: 10.1016/s0140-6736(89)92535-x. [DOI] [PubMed] [Google Scholar]
  30. Gunnarsson L. G., Lindberg G., Söderfeldt B., Axelson O. Amyotrophic lateral sclerosis in Sweden in relation to occupation. Acta Neurol Scand. 1991 Jun;83(6):394–398. doi: 10.1111/j.1600-0404.1991.tb03970.x. [DOI] [PubMed] [Google Scholar]
  31. Hanisch R., Dworsky R. L., Henderson B. E. Letter: A search for clues to the cause of amyotrophic lateral sclerosis. Arch Neurol. 1976 Jun;33(6):456–457. doi: 10.1001/archneur.1976.00500060062015. [DOI] [PubMed] [Google Scholar]
  32. Hawkes C. H., Fox A. J. Motor neurone disease in leather workers. Lancet. 1981 Feb 28;1(8218):507–507. doi: 10.1016/s0140-6736(81)91900-0. [DOI] [PubMed] [Google Scholar]
  33. Kondo K., Tsubaki T. Case-control studies of motor neuron disease: association with mechanical injuries. Arch Neurol. 1981 Apr;38(4):220–226. doi: 10.1001/archneur.1981.00510040046007. [DOI] [PubMed] [Google Scholar]
  34. Kopec J. A., Esdaile J. M. Bias in case-control studies. A review. J Epidemiol Community Health. 1990 Sep;44(3):179–186. doi: 10.1136/jech.44.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kurtzke J. F., Beebe G. W. Epidemiology of amyotrophic lateral sclerosis: 1. A case-control comparison based on ALS deaths. Neurology. 1980 May;30(5):453–462. doi: 10.1212/wnl.30.5.453. [DOI] [PubMed] [Google Scholar]
  36. Kurtzke J. F. Motor neuron(e) disease. Br Med J (Clin Res Ed) 1982 Jan 16;284(6310):141–142. doi: 10.1136/bmj.284.6310.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kurtzke J. F. Risk factors in amyotrophic lateral sclerosis. Adv Neurol. 1991;56:245–270. [PubMed] [Google Scholar]
  38. Lee W. R., Moore M. R. Low level exposure to lead. BMJ. 1990 Sep 15;301(6751):504–506. doi: 10.1136/bmj.301.6751.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Leone M., Chandra V., Schoenberg B. S. Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology. 1987 Aug;37(8):1339–1343. doi: 10.1212/wnl.37.8.1339. [DOI] [PubMed] [Google Scholar]
  40. Martyn C. N., Barker D. J., Osmond C. Motoneuron disease and past poliomyelitis in England and Wales. Lancet. 1988 Jun 11;1(8598):1319–1322. doi: 10.1016/s0140-6736(88)92129-0. [DOI] [PubMed] [Google Scholar]
  41. Martyn C. N., Osmond C. The environment in childhood and risk of motor neuron disease. J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):997–1001. doi: 10.1136/jnnp.55.11.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Martyn C. N. Poliovirus and motor neuron disease. J Neurol. 1990 Oct;237(6):336–338. doi: 10.1007/BF00315655. [DOI] [PubMed] [Google Scholar]
  43. Milanese C., Martin L. Amyotropic lateral sclerosis and trauma. Acta Neurol Belg. 1970 Jul-Aug;70(4):482–491. [PubMed] [Google Scholar]
  44. Mitchell J. D. Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol Clin. 1987 Feb;5(1):43–60. [PubMed] [Google Scholar]
  45. Pall H. S., Williams A. C., Waring R., Elias E. Motoneurone disease as manifestation of pesticide toxicity. Lancet. 1987 Sep 19;2(8560):685–685. doi: 10.1016/s0140-6736(87)92468-8. [DOI] [PubMed] [Google Scholar]
  46. Provinciali L., Giovagnoli A. R. Antecedent events in amyotrophic lateral sclerosis: do they influence clinical onset and progression? Neuroepidemiology. 1990;9(5):255–262. doi: 10.1159/000110782. [DOI] [PubMed] [Google Scholar]
  47. Roelofs-Iverson R. A., Mulder D. W., Elveback L. R., Kurland L. T., Molgaard C. A. ALS and heavy metals: a pilot case-control study. Neurology. 1984 Mar;34(3):393–395. doi: 10.1212/wnl.34.3.393. [DOI] [PubMed] [Google Scholar]
  48. Rosati G., Pinna L., Granieri E., Aiello I., Tola R., Agnetti V., Pirisi A., de Bastiani P. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand. 1977 Mar;55(3):231–244. doi: 10.1111/j.1600-0404.1977.tb05642.x. [DOI] [PubMed] [Google Scholar]
  49. Sackett D. L. Bias in analytic research. J Chronic Dis. 1979;32(1-2):51–63. doi: 10.1016/0021-9681(79)90012-2. [DOI] [PubMed] [Google Scholar]
  50. Sandyk R., Gillman M. A. Motor dysfunction following chronic exposure to a fluoroalkane solvent mixture containing nitromethane. Eur Neurol. 1984;23(6):479–481. doi: 10.1159/000115732. [DOI] [PubMed] [Google Scholar]
  51. Sonies B. C., Dalakas M. C. Dysphagia in patients with the post-polio syndrome. N Engl J Med. 1991 Apr 25;324(17):1162–1167. doi: 10.1056/NEJM199104253241703. [DOI] [PubMed] [Google Scholar]
  52. Stern M., Dulaney E., Gruber S. B., Golbe L., Bergen M., Hurtig H., Gollomp S., Stolley P. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. Arch Neurol. 1991 Sep;48(9):903–907. doi: 10.1001/archneur.1991.00530210029018. [DOI] [PubMed] [Google Scholar]
  53. Steventon G. B., Waring R. H., Williams A. C. Pesticide toxicity and motor neuron disease. J Neurol Neurosurg Psychiatry. 1990 Jul;53(7):621–622. doi: 10.1136/jnnp.53.7.621-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Stober T., Stelte W., Kunze K. Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis. J Neurol Sci. 1983 Sep;61(1):21–26. doi: 10.1016/0022-510x(83)90051-5. [DOI] [PubMed] [Google Scholar]
  55. Yanagihara R. Heavy metals and essential minerals in motor neuron disease. Adv Neurol. 1982;36:233–247. [PubMed] [Google Scholar]
  56. den Hartog Jager W. A., Hanlo P. W., Ansink B. J., Vermeulen M. B. Results of a questionnaire in 100 ALS patients and 100 control cases. Clin Neurol Neurosurg. 1987;89(1):37–41. doi: 10.1016/s0303-8467(87)80074-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES